Mental health and early use linked to cannabis dependency risk

Who is at risk? Core mental health symptoms and problematic cannabis use in Germany.

Journal of cannabis research • • Moderately Relevant
🤖

AI Summary

This nationally representative study from Germany reveals important risk factors for problematic cannabis use among the 25% of cannabis users who develop dependency issues. Researchers surveyed over 1,000 adults about their cannabis consumption patterns and mental health symptoms, finding that individuals with problematic use were significantly more likely to have started using cannabis before age 15, use it weekly or daily, and have lower educational attainment. The research highlights a strong connection between cannabis use patterns and co-occurring substance use, with problematic cannabis users being 5 times more likely to use amphetamines problematically and twice as likely to have problematic tobacco use.

The most striking finding is the relationship between mental health and problematic cannabis use. People with problematic cannabis use were 40.8% more likely to report four or more core mental health symptoms compared to casual users, and when researchers adjusted for other factors, having multiple mental health symptoms remained positively associated with problematic cannabis use (1.68 times higher odds). Conversely, those with no mental health symptoms were significantly less likely to develop problematic use patterns. This suggests that mental health screening could be a valuable tool for identifying individuals at higher risk of developing cannabis dependency.

These findings have important implications as Germany considers changing its cannabis laws. The research identifies multiple interconnected risk factors—early age of use onset, frequency of consumption, mental health challenges, and polysubstance use—that could guide prevention and intervention strategies. Healthcare providers screening cannabis users should pay particular attention to those with multiple mental health symptoms, early use histories, and co-occurring substance use, as these individuals may benefit from targeted support services to prevent problematic use patterns from developing.

📄 Original Abstract

Cannabis is one of the most used psychoactive substances worldwide. This study presents nationally representative data on core mental health symptoms and other characteristics among individuals in Germany who used cannabis in the past 12 months, stratified into those with and without problematic cannabis use. Data were drawn from the 10th wave (2021) of the Epidemiological Survey of Substance Abuse, a cross-sectional survey of adults aged 18-64 years living in private households in Germany. The analytic sample included 1,004 past-year cannabis users. Problematic cannabis use was assessed using the Severity of Dependence Scale with sex-specific cut-offs (≥ 2 for women, ≥ 4 for men). Core mental health symptoms were measured with the DIA-X-Core Screening Questionnaire and categorized into 0, 1-3, or ≥ 4 symptoms. Analyses were weighted to match the German population. Descriptive comparisons between individuals with and without problematic use employed χ2-tests. Multivariable logistic regression models examined associations between problematic use and cumulative symptom scores, adjusting for covariates. P-values were corrected using the Simes-Benjamini-Hochberg procedure. Among individuals with past-year cannabis use, 25.0% met criteria for problematic use. Compared with those without problematic use, these individuals were more likely to have a low educational level (27.2% vs. 10.8%), use cannabis weekly or almost daily (66.8% vs. 14.8%), begin use before age 15 (40.8% vs. 19.1%), currently use tobacco (73.1% vs. 49.7%), and report problematic amphetamine- (10.5% vs. 2.2%) and tobacco use (23.8% vs.14.0%). They were less likely to report no core mental health symptoms (12.7% vs. 25.3%) and more likely to report ≥ 4 symptoms (40.8% vs. 27.2%). Adjusted models showed that reporting ≥ 4 symptoms was positively associated with problematic use (aOR = 1.68; 95% CI [1.12-2.53]; p=.027), whereas having no symptoms was associated negatively (aOR = 0.41; 95% CI [0.23-0.73]; p=.006). Amid changing cannabis laws in Germany, this study identifies risk factors for problematic use and highlights that core mental health symptoms are associated with problematic cannabis use. The findings underscore the importance of early screening and targeted prevention strategies.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.